Indefinite Delivery Contract 36C24E26D0008
Award Date 3/2/26
Last Date to Order 9/1/31
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Akesogen, Inc., operating through its Tempus Labs, Inc. division, holds a single-award Indefinite Delivery Contract valued at $37 million with the Department of Veterans Affairs Headquarters, a civilian agency, to provide comprehensive genomic analysis services in support of the Million Veteran Program. The contract, awarded on September 30, 2020, with an ultimate completion date of March 1, 2026, encompasses genomic sequencing, DNA quality assessment, single nucleotide polymorphism...
- Foundation Medicine, Inc. has been awarded a single-award Indefinite Delivery Contract (IDC) valued at $130.7 million by the Department of Veterans Affairs (VA) Headquarters through September 2026, with no set-aside provisions applied. The contract delivers comprehensive molecular tumor testing and genomic profiling services to support the VA's National Precision Oncology Program, which advances precision cancer diagnosis and treatment selection for the veteran population across all VA...
- The Department of Veterans Affairs (VA) awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract to Foundation Medicine, Inc., a foreign-owned for-profit organization, for genomic sequencing testing services. The potential contract value exceeds $111 million and does not utilize any set-aside designations. Under this IDIQ contract, Foundation Medicine has been awarded multiple firm fixed price delivery orders to provide a range of genomic sequencing, next-generation sequencing (NGS),...
- The Department of Veterans Affairs (VA) Veterans Health Administration has awarded several delivery order contracts to Life Technologies Corporation, a subsidiary of Thermo Electron Corporation, to provide genome reagents and sequencing-related products and services. The initial $3.5 million indefinite delivery contract, established in December 2020, aims to supply the VA's Veterans Integrated Service Network 2 with proprietary ThermoFisher genome reagents and related services through December...
- This federal contract IDV award and associated task orders procure whole genome sequencing services from Personalis, Inc., a genomic sequencing services provider, to support the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its medical research and precision medicine initiatives. The $175 million single award IDV contract, designated as a Total Small Business set-aside, enables Personalis to perform whole genome sequencing across multiple VA facilities,...
- Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, was awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs Veterans Integrated Service Network 22 on February 24, 2023, with a ceiling value of $970,352 and an ultimate completion date of February 23, 2027. The contract procures Oncotype genetic testing services, which encompass gene expression assays for cancer screening, treatment selection, and disease monitoring across breast, prostate, and...
- The Department of Veterans Affairs (VA) has awarded Tasso Inc., a Seattle-based startup, a $5.46 million single-award Indefinite Delivery Contract (IDC) through its Veterans Integrated Service Network 1 (VISN 1) office. The contract, which runs from March 2023 to February 2028, is for the distribution and tracking of self-collection blood sample kits to support the VA's mission of providing quality healthcare to veterans. This IDC has already generated multiple delivery orders totaling over...
- Natera Inc. has been awarded an Indefinite Delivery Contract by the Department of Veterans Affairs, Veterans Integrated Service Network 10, valued at $147,080 with an ultimate completion date of March 2, 2027. The contract is a non-set-aside, single award vehicle for next-generation sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services supporting cancer research initiatives across VA medical centers. The prime contractor will deliver advanced genomic analysis services...
- This federal contract IDV is a Federal Supply Schedule (FSS) award to Guardant Health, Inc. for medical laboratory testing and analysis services, specifically the Guardant360 assay. The contract, valued at up to $700,000, was awarded by the U.S. Department of Veterans Affairs (VA) and runs from September 2020 through August 2025. The Guardant360 assay evaluates blood samples for genomic alterations associated with solid tumor therapy selection using next-generation sequencing of cell-free DNA....
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs Veterans Integrated Service Network 15 on March 16, 2025, with a ceiling value of $1,071,290.72 and an ultimate completion date of March 15, 2027. The contract provides Oncotype DX testing services, a gene expression profiling diagnostic test used to assess cancer recurrence risk and guide personalized treatment decisions...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C24E26D0008-36C24E26N0050 | Tempus AI, Inc. | $2.7m | 3/2/26 | 3/1/27 | 2/11/26 |